» Articles » PMID: 17509799

Production of Extracellular Proteolytic Activity by Histoplasma Capsulatum Grown in Histoplasma-macrophage Medium is Limited to Restriction Fragment Length Polymorphism Class 1 Isolates

Overview
Date 2007 May 19
PMID 17509799
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular proteolytic activity was studied for 28 strains of Histoplasma capsulatum var. capsulatum and 2 strains of H. capsulatum var. duboisii. Secreted protease activity assessed by skim milk agarose clearance was limited solely to H. capsulatum var. capsulatum restriction fragment length polymorphism (RFLP) class 1 strains. There was a difference in proteolytic activity levels among class 1 strains. Extracellular proteolytic activity was further determined during growth of those strains in liquid medium using azodye-impregnated protein substrates. In general, the highest activities were measured when azocollagen was used, whereas azocasein and azoalbumin were cleaved less efficiently. The activity was inhibited by phenylmethylsulfonyl fluoride, 4-(2-aminoethyl) benzenesulfonyl fluoride, antipain, and chymostatin, indicating, thereby, the presence of chymotrypsin-like serine proteases. Chromatographic analyses as well as variable substrate use at different culture times revealed production of at least 2 different enzyme pools of the same serine-like protease family. Our results demonstrate a distinctive ability of RFLP class 1 isolates to produce and secrete serine proteinase-type activity. This peculiarity may be relevant to the biology and pathogenesis of this particular clade of H. capsulatum isolates. Overall, the feature of extracellular proteolytic activity production enables a convenient and unequivocal identification of RFLP class 1 isolates and, thereby, can be used in H. capsulatum strain differentiation and typing.

Citing Articles

Three transporters, including the novel Gai1 permease, drive amino acid uptake in yeasts.

Ray S, Shen Q, Rappleye C Virulence. 2024; 15(1):2438750.

PMID: 39652632 PMC: 11633205. DOI: 10.1080/21505594.2024.2438750.


Phenotypic characterization of cryptic species in the fungal pathogen .

Sepulveda V, Rader J, Li J, Goldman W, Matute D mSphere. 2024; 9(6):e0000924.

PMID: 38771035 PMC: 11332167. DOI: 10.1128/msphere.00009-24.


Study of the probiotic properties of subsp NCIM 5752 and the optimization of whey-based media for the production of its biomass using response surface methodology.

Nanjaiah M, Rastogi N, Devappa S 3 Biotech. 2024; 14(2):49.

PMID: 38268985 PMC: 10803690. DOI: 10.1007/s13205-023-03899-z.


Phenotypic characterization of cryptic species in the fungal pathogen .

Sepulveda V, Rader J, Li J, Goldman W, Matute D bioRxiv. 2024; .

PMID: 38260643 PMC: 10802462. DOI: 10.1101/2024.01.08.574719.


Metabolism of Gluconeogenic Substrates by an Intracellular Fungal Pathogen Circumvents Nutritional Limitations within Macrophages.

Shen Q, Ray S, Evans H, Deepe Jr G, Rappleye C mBio. 2020; 11(2).

PMID: 32265333 PMC: 7157778. DOI: 10.1128/mBio.02712-19.


References
1.
Worsham P, Goldman W . Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores. J Med Vet Mycol. 1988; 26(3):137-43. View

2.
Wheat L . Current diagnosis of histoplasmosis. Trends Microbiol. 2003; 11(10):488-94. DOI: 10.1016/j.tim.2003.08.007. View

3.
Spitzer E, Lasker B, Travis S, Kobayashi G, Medoff G . Use of mitochondrial and ribosomal DNA polymorphisms to classify clinical and soil isolates of Histoplasma capsulatum. Infect Immun. 1989; 57(5):1409-12. PMC: 313291. DOI: 10.1128/iai.57.5.1409-1412.1989. View

4.
Vincent R, Goewert R, Goldman W, Kobayashi G, Lambowitz A, Medoff G . Classification of Histoplasma capsulatum isolates by restriction fragment polymorphisms. J Bacteriol. 1986; 165(3):813-8. PMC: 214500. DOI: 10.1128/jb.165.3.813-818.1986. View

5.
Stone M, Frenkel L, Howard D . Histoplasmosis after multiple trauma. Pediatr Infect Dis J. 1990; 9(10):747-9. View